| pubmed-article:16030081 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16030081 | lifeskim:mentions | umls-concept:C0334889 | lld:lifeskim |
| pubmed-article:16030081 | lifeskim:mentions | umls-concept:C0205147 | lld:lifeskim |
| pubmed-article:16030081 | lifeskim:mentions | umls-concept:C0022423 | lld:lifeskim |
| pubmed-article:16030081 | lifeskim:mentions | umls-concept:C0281481 | lld:lifeskim |
| pubmed-article:16030081 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:16030081 | pubmed:dateCreated | 2005-10-24 | lld:pubmed |
| pubmed-article:16030081 | pubmed:abstractText | The requirement in Northern Ireland to prescribe biological agents according to National Institute for Clinical Excellence/British Society for Rheumatology (NICE/BSR) guidelines and within a fixed budget has created a waiting list for treatment that has no parallel in the Republic of Ireland. The study investigated the bearing this situation may have had on consultants' judgements in the respective areas. | lld:pubmed |
| pubmed-article:16030081 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16030081 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16030081 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:16030081 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16030081 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16030081 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16030081 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16030081 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16030081 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:16030081 | pubmed:issn | 1462-0324 | lld:pubmed |
| pubmed-article:16030081 | pubmed:author | pubmed-author:FitzGeraldOO | lld:pubmed |
| pubmed-article:16030081 | pubmed:author | pubmed-author:O'HaraHH | lld:pubmed |
| pubmed-article:16030081 | pubmed:author | pubmed-author:BellAA | lld:pubmed |
| pubmed-article:16030081 | pubmed:author | pubmed-author:BankII | lld:pubmed |
| pubmed-article:16030081 | pubmed:author | pubmed-author:KeeFF | lld:pubmed |
| pubmed-article:16030081 | pubmed:author | pubmed-author:DempsterMM | lld:pubmed |
| pubmed-article:16030081 | pubmed:author | pubmed-author:SheehyNN | lld:pubmed |
| pubmed-article:16030081 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16030081 | pubmed:volume | 44 | lld:pubmed |
| pubmed-article:16030081 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16030081 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16030081 | pubmed:pagination | 1407-13 | lld:pubmed |
| pubmed-article:16030081 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:16030081 | pubmed:meshHeading | pubmed-meshheading:16030081... | lld:pubmed |
| pubmed-article:16030081 | pubmed:meshHeading | pubmed-meshheading:16030081... | lld:pubmed |
| pubmed-article:16030081 | pubmed:meshHeading | pubmed-meshheading:16030081... | lld:pubmed |
| pubmed-article:16030081 | pubmed:meshHeading | pubmed-meshheading:16030081... | lld:pubmed |
| pubmed-article:16030081 | pubmed:meshHeading | pubmed-meshheading:16030081... | lld:pubmed |
| pubmed-article:16030081 | pubmed:meshHeading | pubmed-meshheading:16030081... | lld:pubmed |
| pubmed-article:16030081 | pubmed:meshHeading | pubmed-meshheading:16030081... | lld:pubmed |
| pubmed-article:16030081 | pubmed:meshHeading | pubmed-meshheading:16030081... | lld:pubmed |
| pubmed-article:16030081 | pubmed:meshHeading | pubmed-meshheading:16030081... | lld:pubmed |
| pubmed-article:16030081 | pubmed:meshHeading | pubmed-meshheading:16030081... | lld:pubmed |
| pubmed-article:16030081 | pubmed:meshHeading | pubmed-meshheading:16030081... | lld:pubmed |
| pubmed-article:16030081 | pubmed:meshHeading | pubmed-meshheading:16030081... | lld:pubmed |
| pubmed-article:16030081 | pubmed:meshHeading | pubmed-meshheading:16030081... | lld:pubmed |
| pubmed-article:16030081 | pubmed:meshHeading | pubmed-meshheading:16030081... | lld:pubmed |
| pubmed-article:16030081 | pubmed:meshHeading | pubmed-meshheading:16030081... | lld:pubmed |
| pubmed-article:16030081 | pubmed:meshHeading | pubmed-meshheading:16030081... | lld:pubmed |
| pubmed-article:16030081 | pubmed:meshHeading | pubmed-meshheading:16030081... | lld:pubmed |
| pubmed-article:16030081 | pubmed:meshHeading | pubmed-meshheading:16030081... | lld:pubmed |
| pubmed-article:16030081 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16030081 | pubmed:articleTitle | Rheumatologists' judgements about the efficacy of anti-TNF therapy in two neighbouring regions. | lld:pubmed |
| pubmed-article:16030081 | pubmed:affiliation | Department of Epidemiology and Public Health, Queen's University of Belfast, Belfast, UK. | lld:pubmed |
| pubmed-article:16030081 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16030081 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:16030081 | pubmed:publicationType | Multicenter Study | lld:pubmed |
